SCHEMBL7714261

SCHEMBL7714261

CCOC(=O)N1CCN(c2nc(N)ncc2Oc2ccc(Cl)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
ALDH1A1 P00352 4/20 0.50
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HPGD P15428 1/20 0.50
TSHR P16473 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HRH2 P25021 1/20 0.47
HRH1 P35367 1/20 0.47
GAA P10253 1/20 0.46
TP53 P04637 2/20 0.46
IDE P14735 1/20 0.45
PI4KB Q9UBF8 1/20 0.45
POLB P06746 2/20 0.44
TRPA1 O75762 1/20 0.43
RAB9A P51151 1/20 0.43
USP2 O75604 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708563 0.87 PI4KB (0.46) ALDH1A1HPGDPI4KBTRPA1
SCHEMBL7711739 0.87 PI4KB (0.48) MAPTALDH1A1LMNASMN1; SMN2HPGD
SCHEMBL7714584 0.85 TRPA1 (0.55) ALDH1A1HPGDPI4KBTRPA1RAB9A
SCHEMBL7712462 0.85 PI4KB (0.53) MAPTLMNASMN1; SMN2HPGDNPSR1
SCHEMBL7714733 0.84 PDGFRB (0.43) MAPTLMNAPI4KBTRPA1MAPK1
SCHEMBL7714367 0.83 PI4KB (0.48) MAPTALDH1A1LMNAHPGDTSHR
SCHEMBL7712411 0.83 PI4KB (0.48) MAPTALDH1A1LMNASMN1; SMN2HPGD
SCHEMBL7714398 0.83 KDM4E (0.43) MAPTALDH1A1LMNAHPGDTSHR
SCHEMBL7714727 0.82 ALDH1A1 (0.51) ALDH1A1LMNANPSR1MEN1KMT2A
SCHEMBL7708416 0.81 HRH4 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed